123 related articles for article (PubMed ID: 3353516)
21. A comparison of gallium-67 single photon emission computed tomography and computed tomography in mediastinal Hodgkin's disease.
Karimjee S; Brada M; Husband J; McCready VR
Eur J Cancer; 1992; 28A(11):1856-7. PubMed ID: 1389526
[TBL] [Abstract][Full Text] [Related]
22. Treatment of Hodgkin's patients with large mediastinal masses.
Kumar PP; Good RR; Scheinos N
Radiat Med; 1987; 5(4):112-20. PubMed ID: 3423298
[TBL] [Abstract][Full Text] [Related]
23. Mediastinal fibrosis simulating residual Hodgkin's disease.
Markman M
Am J Med Sci; 1984; 287(1):40-2. PubMed ID: 6702882
[TBL] [Abstract][Full Text] [Related]
24. Persistent mediastinal mass is not indicative of recurrence after chemotherapy only in paediatric Hodgkin's disease.
Van Den Berg H; Verhulst L; Behrendt H; Staalman CR
Br J Haematol; 2000 Apr; 109(1):104-8. PubMed ID: 10848788
[TBL] [Abstract][Full Text] [Related]
25. The significance of the residual mediastinal mass in treated Hodgkin's disease.
Jochelson M; Mauch P; Balikian J; Rosenthal D; Canellos G
J Clin Oncol; 1985 May; 3(5):637-40. PubMed ID: 3998780
[TBL] [Abstract][Full Text] [Related]
26. Comparison of 18FDG-PET with CT scans in the evaluation of patients with residual and recurrent Hodgkin's lymphoma.
Dittmann H; Sokler M; Kollmannsberger C; Dohmen BM; Baumann C; Kopp A; Bares R; Claussen CD; Kanz L; Bokemeyer C
Oncol Rep; 2001; 8(6):1393-9. PubMed ID: 11605073
[TBL] [Abstract][Full Text] [Related]
27. Residual mediastinal widening following therapy in Hodgkin's disease.
Orlandi E; Lazzarino M; Brusamolino E; Caldera D; Morra E; Dore R; Di Giulio G; Bernasconi C
Hematol Oncol; 1990; 8(3):125-31. PubMed ID: 2373490
[TBL] [Abstract][Full Text] [Related]
28. [Bulky mediastinal lymphomas: role of magnetic resonance and SPECT-Ga-67 in the evaluation of residual masses].
Canini R; Battista G; Monetti N; Pisi P; Fanti S; Zinzani PL; Zompatori M; Bendandi M; Gherlinzoni F; Corinaldesi A
Radiol Med; 1995 Oct; 90(4):448-56. PubMed ID: 8552823
[TBL] [Abstract][Full Text] [Related]
29. Large mediastinal tumor mass as a prognostic factor in Hodgkin's lymphoma. Is the definition on the basis of a chest radiograph in the era of CT obsolete?
Kriz J; Mueller RP; Mueller H; Kuhnert G; Engert A; Kobe C; Haverkamp U; Eich HT
Strahlenther Onkol; 2012 Nov; 188(11):1020-4. PubMed ID: 23053141
[TBL] [Abstract][Full Text] [Related]
30. [Computerized tomography in the staging and the follow-up of Hodgkin's lymphoma of the thorax].
Garribba AP; Ettorre GC; Francioso G; Villani PC; Angone G; Liso V; Specchia G; Pavone V; Capalbo S
Radiol Med; 1990 Dec; 80(6):859-64. PubMed ID: 2281167
[TBL] [Abstract][Full Text] [Related]
31. Regression of mediastinal Hodgkin disease after therapy: evaluation of time interval.
North LB; Fuller LM; Sullivan-Halley JA; Hagemeister FB
Radiology; 1987 Sep; 164(3):599-602. PubMed ID: 3112862
[TBL] [Abstract][Full Text] [Related]
32. Stage IA to IIB mediastinal Hodgkin's disease: three-dimensional volumetric assessment of response to treatment.
Willett CG; Linggood RM; Leong JC; Miketic LM; Stracher MA; Skates SJ; Kushner DC
J Clin Oncol; 1988 May; 6(5):819-24. PubMed ID: 3367187
[TBL] [Abstract][Full Text] [Related]
33. Thoracic wall involvement by Hodgkin disease and non-Hodgkin lymphoma: CT evaluation.
Press GA; Glazer HS; Wasserman TH; Aronberg DJ; Lee JK; Sagel SS
Radiology; 1985 Oct; 157(1):195-8. PubMed ID: 4034966
[TBL] [Abstract][Full Text] [Related]
34. Validation of gallium-67-citrate single-photon emission computed tomography in biopsy-confirmed residual Hodgkin's disease in the mediastinum.
Kostakoglu L; Yeh SD; Portlock C; Heelan R; Yao TJ; Niedzwiecki D; Larson SM
J Nucl Med; 1992 Mar; 33(3):345-50. PubMed ID: 1740700
[TBL] [Abstract][Full Text] [Related]
35. [Does the residual mediastinal mass have prognostic significance in children with Hodgkin's disease (HD)?].
Klekawka T; Balwierz W; Moryl-Bujakowska A; Stanuch H; Matysiak M; Rokicka-Milewska R; Sopyło B; Kołakowska-Mrozowska B; Krenke K; Chybicka A; Chaber R; Sońita-Jakimczyki D; Janik-Moszants A; Wachowiak J; Kaczmarek-Kanold M; Kowalczyk J; Odój T; Balcerska A; Adamkiewicz-Drozyińska E; Wysocki M; Koltan A; Krawczuk-Rybako M; Muszyńska-Rosłan K; Stolarska M
Przegl Lek; 2006; 63(1):21-4. PubMed ID: 16892894
[TBL] [Abstract][Full Text] [Related]
36. MRI characterization of residual mediastinal masses in Hodgkin's disease: long-term follow-up.
Di Cesare E; Cerone G; Enrici RM; Tombolini V; Anselmo P; Masciocchi C
Magn Reson Imaging; 2004 Jan; 22(1):31-8. PubMed ID: 14972392
[TBL] [Abstract][Full Text] [Related]
37. Calcification in untreated mediastinal Hodgkin's lymphoma.
Alobeidy ST; Ilowite J; Donovan V; Selbs E; Badler R; Katz DS
J Thorac Imaging; 2001 Oct; 16(4):304-6. PubMed ID: 11685097
[TBL] [Abstract][Full Text] [Related]
38. CT evaluation of mediastinal masses.
Rebner M; Gross BH; Robertson JM; Pennes DR; Spizarny DL; Glazer GM
Comput Radiol; 1987; 11(3):103-10. PubMed ID: 3608455
[TBL] [Abstract][Full Text] [Related]
39. Comparison of gallium scan, computed tomography, and magnetic resonance in patients with mediastinal Hodgkin's disease.
Devizzi L; Maffioli L; Bonfante V; Viviani S; Balzarini L; Gasparini M; Valagussa P; Bombardieri E; Santoro A; Bonadonna G
Ann Oncol; 1997; 8 Suppl 1():53-6. PubMed ID: 9187430
[TBL] [Abstract][Full Text] [Related]
40. [Residual mediastinal masses after radiotherapy for Hodgkin's disease (author's transl)].
Katz M; Piekarski JD; Bayle-Weisgerber C; Laval-Jeantet M; Teillet F
Ann Radiol (Paris); 1977 Oct; 20(7):667-72. PubMed ID: 931338
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
